Effect of Topiroxostat on Urinary Albumin in hyperuricemic patients with Diabetic nephropathy

Trial Profile

Effect of Topiroxostat on Urinary Albumin in hyperuricemic patients with Diabetic nephropathy

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Oct 2016

At a glance

  • Drugs Topiroxostat (Primary)
  • Indications Diabetic nephropathies; Hyperuricaemia
  • Focus Therapeutic Use
  • Acronyms ETUDE
  • Most Recent Events

    • 12 Oct 2016 Status changed from recruiting to active, no longer recruiting.
    • 17 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top